Showing 1 - 7 results of 7 for search 'Osvaldo García-Pérez', query time: 0.03s Refine Results
  1. 1
    Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent

    Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent by Quetzali Pitalua-Cortes, Francisco Osvaldo García-Perez, Joel Vargas-Ahumada, Sofia Gonzalez-Rueda, Edgar Gomez-Argumosa, Eleazar Ignacio-Alvarez, Irma Soldevilla-Gallardo, Liliana Torres-Agredo

    Published 2021-12-01
    Get full text
    Article
  2. 2
    18F-FDG—PET/CT in Canine Mammary Gland Tumors

    18F-FDG—PET/CT in Canine Mammary Gland Tumors by Diana Sánchez, Diana Sánchez, Laura Romero, Sergio López, Margarita Campuzano, Rocio Ortega, Alfonso Morales, Marina Guadarrama, Gabriela Cesarman-Maus, Osvaldo García-Pérez, Marcela Lizano, Marcela Lizano

    Published 2019-08-01
    Get full text
    Article
  3. 3
    [<sup>99m</sup>Tc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities

    [<sup>99m</sup>Tc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities by Paola Vallejo-Armenta, Guillermina Ferro-Flores, Clara Santos-Cuevas, Francisco Osvaldo García-Pérez, Pamela Casanova-Triviño, Bayron Sandoval-Bonilla, Blanca Ocampo-García, Erika Azorín-Vega, Myrna Luna-Gutiérrez

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Diagnostic Performance of <sup>99m</sup>Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with <sup>18</sup>F-PSMA-1007 PET/CT

    Diagnostic Performance of <sup>99m</sup>Tc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparativ... by Joel E. Vargas-Ahumada, Sofía Denisse González-Rueda, Fabio Andrés Sinisterra-Solís, Pamela Casanova-Triviño, Quetzali Pitalúa-Cortés, Irma Soldevilla-Gallardo, Anna Scavuzzo, Miguel Angel Jimenez-Ríos, Francisco Osvaldo García-Pérez

    Published 2023-12-01
    Get full text
    Article
  5. 5
    <sup>99m</sup>Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe

    <sup>99m</sup>Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe by Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Santos-Cuevas

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation

    Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation by Joel Vargas Ahumada, Sofía D. González Rueda, Fabio A. Sinisterra Solís, Quetzali Pitalúa Cortés, Liliana P. Torres Agredo, Jimenez Ríos Miguel, Anna Scavuzzo, Irma Soldevilla-Gallardo, Miguel A. Álvarez Avitia, Nora Sobrevilla, Francisco Osvaldo García Pérez

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using <sup>177</sup>Lu-iPSMA and <sup>177</sup>Lu-DOTATOC: Experience after 905 Treatment Doses

    Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using <sup>177</sup>Lu-iPSMA and <sup>177</sup>Lu-DOTATOC: Experience afte... by Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, Brenda Gibbens-Bandala, Irma Soldevilla-Gallardo, Nancy Lara-Almazán, Melissa Rojas-Pérez, Blanca Ocampo-García, Erika Azorín-Vega, Clara Santos-Cuevas, Guillermina Ferro-Flores

    Published 2023-07-01
    Get full text
    Article

Search Tools: